Montag A & Associates Inc Boston Scientific Corp Transaction History

Montag A & Associates Inc

$1.97 Billion
Q2 2024

A detailed history of Montag A & Associates Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Montag A & Associates Inc holds 16,300 shares of BSX stock, worth $1.38 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

16,300

Previous 14,587 11.74%

Holding current value

$1.38 Million

Previous $999,000 25.63%

% of portfolio

0.06%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$67.33 - $77.71 $115,336 - $133,117	1,713 Added 11.74%	16,300 $1.26 Million
Q4 2023 Feb 07, 2024	BUY	$48.64 - $57.81 $573,319 - $681,406	11,787 Added 420.96%	14,587 $843,000
Q3 2023 Nov 09, 2023	BUY	$50.19 - $54.68 $4,416 - $4,811	88 Added 3.24%	2,800 $147,000
Q4 2022 Feb 02, 2023	BUY	$39.56 - $47.22 $8,386 - $10,010	212 Added 8.48%	2,712 $125,000
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $82,875 - $104,925	2,500 New	2,500 $90,000
Q1 2020 May 06, 2020	SELL	$25.83 - $45.71 $125,921 - $222,836	-4,875 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$37.87 - $45.37 $4,733 - $5,671	-125 Reduced 2.5%	4,875 $220,000
Q2 2019 Aug 06, 2019	SELL	$34.91 - $42.98 $52,364 - $64,469	-1,500 Reduced 23.08%	5,000 $215,000
Q1 2019 May 01, 2019	SELL	$32.91 - $40.75 $296,189 - $366,750	-9,000 Reduced 58.06%	6,500 $249,000
Q4 2018 Feb 06, 2019	SELL	$31.73 - $39.04 $836,942 - $1.03 Million	-26,377 Reduced 62.99%	15,500 $548,000
Q2 2018 Aug 08, 2018	SELL	$26.84 - $34.32 $89,914 - $114,972	-3,350 Reduced 7.41%	41,877 $1.37 Million
Q2 2018 Aug 01, 2018	BUY	$26.84 - $34.32 $1.21 Million - $1.55 Million	45,227 New	45,227 $1.48 Million

Others Institutions Holding BSX

# of Institutions

1,450

Shares Held

1.21B

Call Options Held

8.14M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $121B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Account

Montag A & Associates Inc Boston Scientific Corp Transaction History